Leonid Heifets

7.8k citations
98 papers · 5.7k · 1 hit paper · h-index 44

Impact in

    • Tuberculosis Research and Epidemiology
  • Epidemiology top 0.2%
    • Mycobacterium research and diagnosis
    • Pneumocystis jirovecii pneumonia detection and treatment

Papers in

    • Mycobacterium research and diagnosis 69
    • Pneumocystis jirovecii pneumonia detection and treatment 8
    • Tuberculosis Research and Epidemiology 69

Leonid Heifets

97 papers receiving 5.5k citations

Leonid Heifets's Hit Papers

The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis 2005 · 551 citations
5510+7+14Years since publication100200300400500

Peers

Leonid Heifets
Comparison fields: 5 of 133
  • Infectious Diseases 3.5k
  • Epidemiology 3.4k
  • Molecular Medicine 529
  • Small Animals 444
  • Microbiology 37
Replace Michael H. Cynamon with:
Michael H. Cynamon United States
Victor Fainstein United States
J. Peter Donnelly Netherlands
Michael D. Iseman United States
Anandi Martin Belgium
Irma A. J. M. Bakker‐Woudenberg Netherlands
Eric L. Nuermberger United States
George A. Pankey United States
E. Anaissie United States
Roy L. Hopfer United States
Leonid Heifets relative to Michael H. Cynamon United States Michael H. Cynamon's profile →
Citations per field
00.5×2.6×
Michael H. Cynamon · 1×
Citations per year

Countries citing papers authored by Leonid Heifets

Since Specialization
Citations

This map shows the geographic impact of Leonid Heifets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Heifets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Heifets more than expected).

Fields of papers citing papers by Leonid Heifets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonid Heifets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Heifets. The network helps show where Leonid Heifets may publish in the future.

Co-authors

The 25 scholars most cited alongside Leonid Heifets, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Leonid Heifets Line = papers co-authored together Leonid Heifets links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis
Hit paper breakdown →
2005551
2 2005250
3 2003247
4 1996192
5 1998185
6 2002150
7 2012147
8
Drug Susceptibility in the Chemotherapy of Mycobacterial Infections
1991135
9 2002134
10 2000132
11 1992131
12 2012127
13 2000121
14 1988114
15 1988111
16
Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century.
1999111
17 2007100
18 199895
19 199088
20 199287

About Leonid Heifets

Leonid Heifets is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Organic Chemistry and Molecular Medicine, having authored 98 papers that have together received 5.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (69 papers), Mycobacterium research and diagnosis (69 papers), Quinazolinone synthesis and applications (12 papers), Antibiotic Resistance in Bacteria (11 papers), Phenothiazines and Benzothiazines Synthesis and Activities (11 papers), Cancer therapeutics and mechanisms (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). The work is most often cited by research in Infectious Diseases (3.5k citations), Epidemiology (3.4k citations), Molecular Medicine (529 citations), Small Animals (444 citations) and Microbiology (37 citations). Leonid Heifets has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Pamela J. Lindholm-Levy, Kevin O. Kisich, Michael D. Iseman, Svetlana Gelperina, N Mor, Michael H. Cynamon, M D Iseman, Max Salfinger, Michael Higgins and Charles L. Daley. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Clinical Infectious Diseases, American Journal of Respiratory and Critical Care Medicine and Seminars in Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact